Drug Discovery Expert Witnesses
Drug discovery disputes arise because the earliest stages of pharmaceutical research create the assets on which later commercial value depends. Patent litigation over compound, genus, and method-of-treatment claims frequently turns on what medicinal chemists and biologists knew, predicted, or could reasonably have pursued at the time of invention. Research collaborations, licensing agreements, and acquisitions generate their own conflicts when parties disagree about inventorship, the ownership of leads identified during a partnership, or whether a counterparty used commercially reasonable efforts to advance a program. Trade secret claims involving screening data, structure-activity relationships, and target validation work raise similarly contested questions about what was truly proprietary.
A drug discovery expert helps counsel reconstruct the scientific landscape and test each side's account of how a program actually progressed. In patent matters, that often means analyzing lead identification and optimization from the perspective of a person of ordinary skill, assessing whether the prior art provided a reason to select a particular compound, and evaluating enablement and written description for broad genus or functional claims. In contract, earnout, and trade secret disputes, the expert can review laboratory notebooks, assay data, and portfolio decisions to determine whether a program's trajectory reflected sound scientific judgment, misappropriated information, or a counterparty's failure to perform. That analysis anchors liability and gives damages experts a defensible view of the program's probability of success.
Opinions on drug discovery carry weight when they come from scientists who have made real go and no-go decisions on research programs. Round Table Group can identify medicinal chemists, pharmacologists, and translational scientists whose careers include organizations such as Pfizer, Merck, Genentech, and the National Institutes of Health, along with faculty who lead academic discovery laboratories. Experts with those backgrounds understand how targets are validated, how leads are optimized, and how portfolio decisions are actually made inside pharmaceutical companies, which makes their testimony grounded rather than theoretical. We've completed more than 75,000 expert searches for litigators and can match the therapeutic area and stage of research your case involves. Let us help you find the right expert for your drug discovery matter by calling us at (202) 908-4500.